Prelude TX
Prelude Therapeutics is a leading precision oncology company dedicated to the development of innovative medicines aimed at addressing high unmet needs among cancer patients. Their pipeline includes several novel drug candidates, such as first-in-class highly selective SMARCA2 and KAT6A degraders, along with precision antibody-drug conjugates (ADCs).
Driven by a bold scientific approach, Prelude Therapeutics focuses on turning scientific insights into effective and safe therapies, striving to improve the lives of patients battling cancer. With a range of programs advancing into clinical trials, the company emphasizes a patient-centric mission to extend the promise of precision medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


